← Back to AARD

Aardvark Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 11/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/08/2025Mar 2024Filed 14/05/2025
$0.7$0$1.4$1.5$0$1$0.6$0.1
−$14−$22−$16−$14−$9.3−$4.2−$5.4−$2.2
−$0.66−$0.99−$0.75−$0.66−$0.71−$1.05−$1.37−$0.55
2222222213444

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.